3PBIOVIAN has obtained the French CIR (Crédit d’Impôt Recherche) certification at its two production and development sites: Turku (Finland) and Pamplona (Spain).
The certification is valid until 2027 and strengthens the company’s position as a strategic partner for international R&D projects.
The CIR certification officially recognises the eligibility of 3PBIOVIAN’s services for French companies’ research and development programmes, enabling partners to benefit from tax incentives when collaborating with the company.
This framework provides an additional competitive advantage and supports the launch of new scientific and technological projects.
The Turku site has obtained the certification for the first time, while the Pamplona site has completed its recertification process, having previously held this recognition.
As a result, both sites now hold a fully valid CIR certification.
This milestone reinforces 3PBIOVIAN’s ability to deliver end-to-end solutions, covering both the development and manufacturing of recombinant proteins and advanced therapies and underlines its commitment to scientific excellence and innovation.
The achievement reflects its ongoing commitment to delivering high-value services, driving technological development and fostering international collaboration, with the mission of enhancing clients’ operational excellence and ensuring that biotechnological advances reach those who matter most: patients.